Patents

US 8962010 B2: Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs

Granted
2015-02-24
Filed
2008-06-26 application 12147310
Type
Utility · 29 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

An intravaginal drug delivery device comprises a device body comprising a hydrophobic carrier material having at least one channel defining at least one opening to the exterior of said device body, said at least one channel being adapted to receive at least one drug-containing insert; at least one drug-containing insert positioned in said at least one channel, said drug-containing insert capable of releasing a pharmaceutically effective amount of at least one drug suitable for intravaginal administration and containing about 1% to about 70% of at least one water-soluble release enhancer, both the drug and the water-soluble release enhancer dispersed in an insert carrier material; wherein said hydrophobic carrier material and said insert carrier material may be the same or different; and wherein said at least one drug-containing insert is exposed on said exterior of said device body when said intravaginal drug delivery device is in use.

Source: PVGPATDIS, file of 2026-04-10 (ipg150224.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Warner Chilcott Company, LLC 27 patentsUS company or organizationRockaway, NJWARNER CHILCOTT COMPANY, LLC State business registration EXACT high confidence: identical full name and state
WARNER CHILCOTT PLC SEC filer FUZZY low confidence: same name (legal endings aside), one of each nationally
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
David WoolfsonFoxford, IE11PVGPATDIS, file of 2026-04-10
Karl MalcolmFoxford, IE7PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K9/0036PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P31/18PVGPATDIS, file of 2026-04-10
C07KPeptidesC07K14/005PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N2740/16034PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2018-02-22Correction
Corrective assignment to correct the us patent no. 8,050,873 previously recorded on reel 040183 frame 0129. assignor(s) hereby confirms the assignment.
WARNER CHILCOTT COMPANY, LLC signed 2015-12-31ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED DUBLIN 1745417/593PASDL, file of 2026-10-15
2016-09-29Assignment
Assignment of assignor's interest
WARNER CHILCOTT COMPANY, LLC signed 2015-12-31ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED DUBLIN 1740183/129PASDL, file of 2026-10-15
2013-10-31Release of security interest
Release of security interest
BANK OF AMERICA, N.A., AS COLLATERAL AGENT signed 2013-10-01WARNER CHILCOTT COMPANY, LLC ROCKAWAY, NJ31531/538PASDL, file of 2026-10-15
2011-03-30Security interest Security interest
Security agreement
WARNER CHILCOTT COMPANY LLC signed 2011-03-17BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT CHARLOTTE, NC26064/607PASDL, file of 2026-10-15
2011-03-29Release of security interest
Release - reel 023456, frame 0052
CREDIT SUISSSE AG, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT signed 2011-03-17WARNER CHILCOTT COMPANY LLC FARJARDO, PR26042/46ECORSEXC, file of 2026-09-25
2009-11-02Security interest Security interest
Security agreement
WARNER CHILCOTT COMPANY, LLC signed 2009-10-30CREDIT SUISSE, CAYMAN ISLANDS BRANCH, AS ADMINISTRATIVE AGENT NEW YORK, NY23456/52ECORSEXC, file of 2026-09-25
2009-06-18Name change
Change of name
WARNER CHILCOTT COMPANY, INC. signed 2009-04-13WARNER CHILCOTT COMPANY, LLC FAJARDO, PR22835/896PASDL, file of 2026-10-15
2008-09-05Assignment
Assignment of assignor's interest
MALCOLM, KARL signed 2008-08-05
WOOLFSON, DAVID signed 2008-08-05
WARNER CHILCOTT COMPANY, INC. FAJARDO, PR21487/770ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.